pentobarbital will lower the level or influence of etravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will minimize the level or outcome of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of abemaciclib with powerful CYP3A4 inducers minimizes plasma concentration of abemaciclib and its metabolites.

Reserve concomitant prescribing of such drugs in clients for whom other treatment solutions are inadequate. Restrict dosages and durations to your minimum essential. Watch intently for signs of respiratory depression and sedation.

Physical exercise warning whenever a barbiturate is administered to a nursing girl; tiny quantities of barbiturates are excreted inside the milk

If this drug is used in the course of pregnancy, or If your client results in being Expecting when having this drug, the affected individual really should be apprised of the prospective hazard to your fetus

Observe Carefully (1)pentobarbital will minimize the extent or effect of exemestane by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. For clients getting exemestane with a strong CYP3A4 inducer the recommended dose of exemestane is fifty mg everyday following a food.

pentobarbital will lower the extent or impact of sufentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.

pentobarbital will lower the level or effect of nelfinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will reduce the level or outcome of conjugated estrogens, vaginal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

This drug may interfere with the absorption of orally administered griseofulvin, decreasing its blood levels; effects of blood degree reduction not known; preferable to stop concomitant administration of such drugs

pentobarbital will lessen the level or read more impact of tamoxifen by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lessen the level or outcome of paclitaxel protein certain by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.

pentobarbital will reduce the level or impact of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.

pentobarbital will reduce the extent or influence of tofacitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Loss of, or decreased reaction to tofacitinib may possibly arise when coadministered with potent CYP3A4 inducers